Published on : Oct 27, 2016
ALBANY, NY, Oct 27, 2016: The report, titled “Global Immunohematology Market 2016 – 2020,” is an in-depth analysis of the factors that are associated with the growth or restriction of the market. The report provides this information using proven research methodologies for a forecast period from 2016 to 2020. This is achieved by calculating possible outcomes from current market facts and figures.
According to the report, the key driver augmenting the growth rate of the global immunohematology market is the growing demand for blood banks across the world. With the growing number of patients suffering from cancer, chronic diseases, geriatric diseases, and road accidents, healthcare organizations are in a great need of blood and blood components. This is allowing this global immunohematology market to expand at a CAGR of 4.79% within a forecast period from 2016 to 2020.
However, the global immunohematology market is currently restrained by high costs associated with the maintenance of blood components. Blood components such as plasma can be difficult to keep usable while in transit or in storage for long periods. The cost of maintaining blood components is therefore high due to the need for premium and advanced preservation equipment. Additionally, the global immunohematology market suffers a setback from the lack of favorable reimbursement policies provided by private players or government bodies. This could change in the future as government organizations are steadily increasing their focus towards the global immunohematology market.
Click to get more details with TOC in a PDF Format: https://www.researchmoz.us/enquiry.php?type=S&repid=834755
Currently, a key trend affecting the global immunohematology market is the growing appeal of molecular immunohematology. The paradigm shift for many companies and research organizations from conventional methods in immunohematology to molecular immunohematology is noteworthy for all players in the market.
Blood loss is a critical problem handled by the healthcare sector during the treatment of a patient. Varying types of problems can be caused by different degrees of blood loss. Major cases of blood loss or anemia can cause chronic disorders in patients. As a result, doctors and medical personnel need to be specifically careful during surgery, wound treating, and blood transfusion in order to avoid the patient from suffering any further complications. Immunohematology, more commonly known as blood banking, allows a healthcare organization to screen for blood antigens and blood components such as white blood cells, plasma, or the Rhesus factor. This is extremely critical as it avoids the scope of a patient contracting diseases such as HIV through blood transfusion.
The key players in the global immunohematology market include Bio-Rad Laboratories, Ortho Clinical Diagnostics, Immucor, and Grifols. Other prominent vendors mentioned in the report include Agena Bioscience, BD, Beckman Coulter, Institut de Biotechnologies Jacques Boy, Hemo Bioscience, Biosurfit SA, Lorne Laboratories, Cardinal Health, Reagens, Seqirus, Tulip, MTC INVITRO, DIAGAST, and Quotient.
To order report Call USA – Canada Toll Free: 866-997-4948 or send an email on email@example.com